FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

424143008: Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet (clinical drug)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3682831017 Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3682833019 Glimepiride 2 mg and rosiglitazone maleate 4 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4725881000005119 rosiglitazon 4 mg + glimepirid 2 mg tablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    rosiglitazon 4 mg + glimepirid 2 mg tablet Is a Product containing glimepiride and rosiglitazone (medicinal product) false Inferred relationship Some
    rosiglitazon 4 mg + glimepirid 2 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glimepiride (substance) false Inferred relationship Some
    rosiglitazon 4 mg + glimepirid 2 mg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
    rosiglitazon 4 mg + glimepirid 2 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Rosiglitazone (substance) false Inferred relationship Some
    rosiglitazon 4 mg + glimepirid 2 mg tablet Has manufactured dose form Oral tablet false Inferred relationship Some
    rosiglitazon 4 mg + glimepirid 2 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Rosiglitazone maleate false Inferred relationship Some
    rosiglitazon 4 mg + glimepirid 2 mg tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Some
    rosiglitazon 4 mg + glimepirid 2 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glimepiride (substance) false Inferred relationship Some 1
    rosiglitazon 4 mg + glimepirid 2 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Glimepiride (substance) false Inferred relationship Some 1
    rosiglitazon 4 mg + glimepirid 2 mg tablet Has presentation strength numerator value to false Inferred relationship Some 1
    rosiglitazon 4 mg + glimepirid 2 mg tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 1
    rosiglitazon 4 mg + glimepirid 2 mg tablet Has presentation strength denominator value en false Inferred relationship Some 1
    rosiglitazon 4 mg + glimepirid 2 mg tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) false Inferred relationship Some 1
    rosiglitazon 4 mg + glimepirid 2 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Rosiglitazone maleate false Inferred relationship Some 2
    rosiglitazon 4 mg + glimepirid 2 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Rosiglitazone maleate false Inferred relationship Some 2
    rosiglitazon 4 mg + glimepirid 2 mg tablet Has presentation strength numerator value fire false Inferred relationship Some 2
    rosiglitazon 4 mg + glimepirid 2 mg tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 2
    rosiglitazon 4 mg + glimepirid 2 mg tablet Has presentation strength denominator value en false Inferred relationship Some 2
    rosiglitazon 4 mg + glimepirid 2 mg tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) false Inferred relationship Some 2
    rosiglitazon 4 mg + glimepirid 2 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Glimepiride (substance) false Inferred relationship Some 1
    rosiglitazon 4 mg + glimepirid 2 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Rosiglitazone maleate false Inferred relationship Some 2
    rosiglitazon 4 mg + glimepirid 2 mg tablet Has unit of presentation Tablet (unit of presentation) false Inferred relationship Some
    rosiglitazon 4 mg + glimepirid 2 mg tablet Is a Glimepiride- and rosiglitazone-containing product in oral dose form false Inferred relationship Some
    rosiglitazon 4 mg + glimepirid 2 mg tablet Count of base of active ingredient to false Inferred relationship Some
    rosiglitazon 4 mg + glimepirid 2 mg tablet Is a Glimepiride and rosiglitazone only product in oral dose form false Inferred relationship Some
    rosiglitazon 4 mg + glimepirid 2 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Rosiglitazone maleate false Inferred relationship Some 1
    rosiglitazon 4 mg + glimepirid 2 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Rosiglitazone maleate false Inferred relationship Some 1
    rosiglitazon 4 mg + glimepirid 2 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Glimepiride (substance) false Inferred relationship Some 2
    rosiglitazon 4 mg + glimepirid 2 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Glimepiride (substance) false Inferred relationship Some 2

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start